Algorithm that we follow for tailoring treatment of children with BM relapse of ALL according to the length of CR1, the immunophenotype of ALL, the presence of cytogenetic abnormalities, and the level of MRD after induction/consolidation therapy. IEM indicates isolated extramedullary relapse.